Literature DB >> 18845561

Targeting calcium handling in arrhythmias.

Gudrun Antoons1, Karin R Sipido.   

Abstract

Abnormal calcium (Ca) handling can contribute to arrhythmogenesis directly by triggering abnormal depolarizations and indirectly by modulating action potential time course and duration. Recent data have shown the importance of these mechanisms in rare genetic diseases but also in more common conditions such as heart failure. Modulating Ca release from the sarcoplasmic reticulum via the ryanodine receptor, Ca uptake via sarcoplasmic reticulum Ca ATPase or Ca removal from the cell via the Na/Ca exchanger, are potential approaches to reduce arrhythmias. New tools allow exploring these ideas. The principles underlying this approach and the first results are critically reviewed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845561     DOI: 10.1093/europace/eun271

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  12 in total

1.  A new cell-penetrating peptide that blocks the autoinhibitory XIP domain of NCX1 and enhances antiporter activity.

Authors:  Pasquale Molinaro; Anna Pannaccione; Maria José Sisalli; Agnese Secondo; Ornella Cuomo; Rossana Sirabella; Maria Cantile; Roselia Ciccone; Antonella Scorziello; Gianfranco di Renzo; Lucio Annunziato
Journal:  Mol Ther       Date:  2014-12-11       Impact factor: 11.454

Review 2.  L-type calcium channel targeting and local signalling in cardiac myocytes.

Authors:  Robin M Shaw; Henry M Colecraft
Journal:  Cardiovasc Res       Date:  2013-02-14       Impact factor: 10.787

Review 3.  Cardiac electrical remodeling in health and disease.

Authors:  Michael J Cutler; Darwin Jeyaraj; David S Rosenbaum
Journal:  Trends Pharmacol Sci       Date:  2011-03       Impact factor: 14.819

4.  Mechanistic distinction between activation and inhibition of (Na(+)+K(+))-ATPase-mediated Ca2+ influx in cardiomyocytes.

Authors:  Kai Y Xu; Weizhong Zhu; Ling Chen; Christopher DeFilippi; Jin Zhang; Rui-Ping Xiao
Journal:  Biochem Biophys Res Commun       Date:  2011-02-15       Impact factor: 3.575

5.  Persistent increases in Ca(2+) influx through Cav1.2 shortens action potential and causes Ca(2+) overload-induced afterdepolarizations and arrhythmias.

Authors:  Xiaoying Zhang; Xiaojie Ai; Hiroyuki Nakayama; Biyi Chen; David M Harris; Mingxin Tang; Yuping Xie; Christopher Szeto; Yingxin Li; Ying Li; Hongyu Zhang; Andrea D Eckhart; Walter J Koch; Jeffery D Molkentin; Xiongwen Chen
Journal:  Basic Res Cardiol       Date:  2015-11-26       Impact factor: 17.165

Review 6.  Cardiac Na+/Ca2+ exchange stimulators among cardioprotective drugs.

Authors:  Yasuhide Watanabe
Journal:  J Physiol Sci       Date:  2019-10-29       Impact factor: 2.781

7.  Current and emerging antiarrhythmic drug therapy for ventricular tachycardia.

Authors:  Eric S Williams; Mohan N Viswanathan
Journal:  Cardiol Ther       Date:  2013-02-20

8.  Flecainide ameliorates arrhythmogenicity through NCX flux in Andersen-Tawil syndrome-iPS cell-derived cardiomyocytes.

Authors:  Yusuke Kuroda; Shinsuke Yuasa; Yasuhide Watanabe; Shogo Ito; Toru Egashira; Tomohisa Seki; Tetsuhisa Hattori; Seiko Ohno; Masaki Kodaira; Tomoyuki Suzuki; Hisayuki Hashimoto; Shinichiro Okata; Atsushi Tanaka; Yoshiyasu Aizawa; Mitsushige Murata; Takeshi Aiba; Naomasa Makita; Tetsushi Furukawa; Wataru Shimizu; Itsuo Kodama; Satoshi Ogawa; Norito Kokubun; Hitoshi Horigome; Minoru Horie; Kaichiro Kamiya; Keiichi Fukuda
Journal:  Biochem Biophys Rep       Date:  2017-01-11

9.  Gene Transfer of Engineered Calmodulin Alleviates Ventricular Arrhythmias in a Calsequestrin-Associated Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia.

Authors:  Bin Liu; Shane D Walton; Hsiang-Ting Ho; Andriy E Belevych; Svetlana B Tikunova; Ingrid Bonilla; Vikram Shettigar; Bjorn C Knollmann; Silvia G Priori; Pompeo Volpe; Przemysław B Radwański; Jonathan P Davis; Sándor Györke
Journal:  J Am Heart Assoc       Date:  2018-05-02       Impact factor: 5.501

Review 10.  Targeting Ca2 + Handling Proteins for the Treatment of Heart Failure and Arrhythmias.

Authors:  Alexandra Njegic; Claire Wilson; Elizabeth J Cartwright
Journal:  Front Physiol       Date:  2020-09-04       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.